The win for ethics is a loss for therapies
The decision by the Court of Justice for the European Union (CJEU) on stem cell patents is a major blow to the UK’s biopharmaceutical industry and is one of the most definitive rulings yet to come down on the side of ethics over therapies. However, supporters of the Court’s decision may not be expecting what is likely to happen next.
By Rachel Wallis | Notebook, Science & Technology | Wednesday, 2 November 2011 at 1:30 pm
Most viewed
|
|
Property search
welsh language
SPOT festival
BBQ
Ian McKellen
Imperial College
PureGold Festival
Vicious
The Fall
sakura
abu sakkar
ben ainslie
folly
23rd November
BUAV
The Barking Hour
Field Day
Maize
association football
cooperative
reality of power
Derek jacobi
play-offs
cannibal
puppy vaccination
British Union for the Abolition of Vivisection
Latest from Independent journalists on Twitter